1. Home
  2. EQBK vs CADL Comparison

EQBK vs CADL Comparison

Compare EQBK & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Equity Bancshares Inc.

EQBK

Equity Bancshares Inc.

HOLD

Current Price

$48.68

Market Cap

1.0B

Sector

Finance

ML Signal

HOLD

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

HOLD

Current Price

$11.22

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EQBK
CADL
Founded
2002
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.0B
IPO Year
2015
2021

Fundamental Metrics

Financial Performance
Metric
EQBK
CADL
Price
$48.68
$11.22
Analyst Decision
Hold
Strong Buy
Analyst Count
3
7
Target Price
★ $51.33
$19.00
AVG Volume (30 Days)
73.7K
★ 1.1M
Earning Date
04-14-2026
05-14-2026
Dividend Yield
★ 1.59%
N/A
EPS Growth
N/A
★ 58.62
EPS
★ 2.06
N/A
Revenue
N/A
★ $125,000.00
Revenue This Year
$74.58
N/A
Revenue Next Year
$5.11
N/A
P/E Ratio
$23.38
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$38.60
$4.35
52 Week High
$52.27
$14.00

Technical Indicators

Market Signals
Indicator
EQBK
CADL
Relative Strength Index (RSI) 43.05 46.11
Support Level $48.53 $9.40
Resistance Level $51.93 $14.00
Average True Range (ATR) 1.05 0.76
MACD -0.15 -0.09
Stochastic Oscillator 31.06 44.47

Price Performance

Historical Comparison
EQBK
CADL

About EQBK Equity Bancshares Inc.

Equity Bancshares Inc is a bank holding company. It provides a broad range of financial services to businesses and business owners as well as individuals through network of nearly 77 branches located in Arkansas, Kansas, Missouri and Oklahoma. The majority of the Company's revenues come from interest income on financial instruments, including loans, leases, securities and derivatives. The company also earns revenue from Non-interest income which includes Service charges and fees, Debit card income, Investment Referral Income, Trust Income and Insurance Sales Commissions.

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

Share on Social Networks: